Several studies reported an increased concentration of RBP4 in obesity [9, 55–57] and in conditions related to obesity complications, including metabolic syndrome [58, 59], diabetes [9, 10, 60] and cardiovascular diseases [61–63]. Here, RBP4 is linked to cardiovascular disorder.